ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 2 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,978 | +38.9% | 1,078 | +10.1% | 0.05% | +39.5% |
| Q2 2023 | $381,546 | +13.2% | 979 | +8.2% | 0.04% | +8.6% |
| Q1 2023 | $337,185 | -10.1% | 905 | -8.6% | 0.04% | -18.6% |
| Q4 2022 | $375,042 | -8.1% | 990 | -14.4% | 0.04% | -20.4% |
| Q3 2022 | $408,000 | +22.2% | 1,157 | +31.3% | 0.05% | +20.0% |
| Q2 2022 | $334,000 | +78.6% | 881 | +48.3% | 0.04% | +95.7% |
| Q1 2022 | $187,000 | +13.3% | 594 | +26.1% | 0.02% | +15.0% |
| Q4 2021 | $165,000 | +39.8% | 471 | +20.2% | 0.02% | +25.0% |
| Q3 2021 | $118,000 | +12.4% | 392 | +12.6% | 0.02% | +6.7% |
| Q2 2021 | $105,000 | +23.5% | 348 | +12.6% | 0.02% | +7.1% |
| Q1 2021 | $85,000 | +28.8% | 309 | +38.6% | 0.01% | +16.7% |
| Q4 2020 | $66,000 | +73.7% | 223 | +54.9% | 0.01% | +50.0% |
| Q3 2020 | $38,000 | +1800.0% | 144 | +1340.0% | 0.01% | – |
| Q2 2020 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |